IGI Laboratories To Hold Conference Call For 4th Quarter 2013 Results

February 14, 2014

BUENA, N.J., Feb. 14, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Thursday, February 27, 2014 to discuss the 4th quarter 2013 results.

(Logo: http://photos.prnewswire.com/prnh/20130827/MM70487LOGO)

The Company invites you to listen to the call by dialing 1-866-515-2908. International participants should call 1-617-399-5122. The passcode for the conference call is 49729279.

This call is being webcast by Thomson and can be accessed at IGI's website at www.igilabs.com.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents (www.streetevents.com), a password-protected event management site.

About IGI Laboratories, Inc.

IGI Laboratories is a generic topical pharmaceutical company.  We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.


SOURCE IGI Laboratories, Inc.

For further information: Jenniffer Collins, IGI Laboratories, Inc., (856) 697-1441, www.igilabs.com